Stock ALBPS BIOPHYTIS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biophytis S.A.

Equities

ALBPS

FR0012816825

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 11:35:28 2024-04-26 EDT 		5-day change 1st Jan Change
0.0023 EUR +4.55% Intraday chart for Biophytis S.A. -4.17% -54.90%
04-25 European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
04-25 Top Premarket Decliners MT

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 91.84 62.22 7.534 3.635 2.632 - -
Enterprise Value (EV) 1 91.84 62.22 7.534 3.635 2.632 2.632 2.632
P/E ratio -3.29 x -1.9 x - - - - -
Yield - - - - - - -
Capitalization / Revenue - - - - 0.57 x 0.14 x 0.08 x
EV / Revenue - - - - 0.57 x 0.14 x 0.08 x
EV / EBITDA - - -0.33 x - -0.21 x -0.47 x 0.77 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 99,720 125,718 163,775 712,819 1,144,342 - -
Reference price 2 0.9210 0.4949 0.0460 0.005100 0.002300 0.002300 0.002300
Announcement Date 21-03-12 22-04-07 23-04-19 24-04-08 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - 4.6 18.2 35
EBITDA 1 - - -22.79 - -12.5 -5.6 3.4
EBIT 1 - -26.82 -23.27 -14.33 -12.5 -5.6 3.4
Operating Margin - - - - -271.74% -30.77% 9.71%
Earnings before Tax (EBT) 1 - -31.25 -24.22 -17.03 -17.5 -8.6 0.4
Net income 1 -17.05 -31.25 -24.22 -17.03 -17.5 -8.6 0.4
Net margin - - - - -380.43% -47.25% 1.14%
EPS -0.2800 -0.2600 - - - - -
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 21-03-12 22-04-07 23-04-19 24-04-08 - - -
1EUR in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales 1 - - - - - -
EBITDA - - -11.77 -11.02 -6.268 -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - -18 -12.4 -11.82 -7.764 -
Net income -15.86 -18 -12.4 -11.82 -7.764 -
Net margin - - - - - -
EPS -0.1400 -0.1400 -0.0800 - - -
Dividend per Share - - - - - -
Announcement Date 21-09-17 22-04-07 23-01-31 23-04-19 23-09-27 24-04-08
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 21-03-12 22-04-07 23-04-19 24-04-08 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
BIOPHYTIS S.A. Stock Biophytis S.A.
-54.90% 2.81M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ALBPS Stock
  4. Financials Biophytis S.A.